TCF3 activates super-enhancer-driven TRIB2 overexpression to suppress ferroptosis and promote hepatoblastoma proliferation
Han Wu, Guoqing Zhu, Qianshu Zhu, Ji Ma, Siwei Mao, Miao Ding, Jiabei Zhu, Xiaochen Tang, Zhixuan Bian, Yuhua Shan, Song Gu, Fenyong Sun, Cizhong Jiang, Qiuhui Pan · 2025
Read TCF3 activates super-enhancer-driven TRIB2 overexpression to suppress ferroptosis and promote hepatoblastoma proliferation by Han Wu, Guoqing Zhu, Qianshu Zhu, Ji Ma, Siwei Mao, Miao Ding, Jiabei Zhu, Xiaochen Tang, Zhixuan Bian, Yuhua Shan, Song Gu, Fenyong Sun, Cizhong Jiang, Qiuhui Pan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12750601.txt.
Description
Han Wu and co-authors found a gene circuit that drives a childhood liver cancer in 2025. Hepatoblastoma is the most common liver cancer in children, and its gene control wiring is poorly mapped. The team built 3D maps of DNA folding and activity in tumors and matched healthy tissue.
A gene called TRIB2 stood out, driven by a strong enhancer unique to the tumors. Extra TRIB2 sped cell growth in lab and animal tests and tied to advanced stage in patients. A switch factor, TCF3, binds both the enhancer and the gene start to raise its output. TRIB2 also blocks a form of iron-driven cell death, which helps tumors resist stress.
Catalog record
| CREATOR | Han Wu, Guoqing Zhu, Qianshu Zhu, Ji Ma, Siwei Mao, Miao Ding, Jiabei Zhu, Xiaochen Tang, Zhixuan Bian, Yuhua Shan, Song Gu, Fenyong Sun, Cizhong Jiang, Qiuhui Pan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |